ANMCO/ELAS/SIBioC Consensus Document: Biomarkers in heart failure [PDF]
Biomarkers have dramatically impacted the way heart failure (HF) patients are evaluated and managed. A biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biological or pathogenic processes, or ...
Aimo, Alberto +15 more
core +1 more source
Vascular Endothelial Effects of Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction: Randomized Controlled Trial [PDF]
BACKGROUND The mechanism of how sacubitril/valsartan improves outcomes in heart failure with reduced ejection fraction (HFrEF) is still incompletely understood.
Barthelmes, Jens +9 more
core +1 more source
Background and objective Dyslipidemia is significantly more common in those with concurrent chronic kidney disease (CKD) and chronic heart failure (CHF).
Manzhi Li +6 more
doaj +1 more source
Induction of ischaemic cardiomyopathy in mice without off‐target effects
Experimental Physiology, EarlyView.
Mark T. Waddingham, James T. Pearson
wiley +1 more source
The effect of angiotensin receptor neprilysin inhibitor, sacubitril/valsartan, on central nervous system amyloid-β concentrations and clearance in the cynomolgus monkey [PDF]
Bateman, Randy J, et al,
core +2 more sources
Comparison of the effect of Sacubitril /Valsartan with Losartan and Captopril in improving right ventricular function in patients with right heart failure, a randomized clinical controlled trial [PDF]
Background: There is evidence supporting the efficacy of Sacubitril /Valsartan for improving left heart failure, but few studies have examined its effects on right ventricular (RV) dysfunction.
Hajahmadi, Marjan +3 more
core +2 more sources
Sacubitril/valsartan, an angiotensin receptor‐neprilysin inhibitor, has demonstrated a superior blood pressure‐lowering effect compared with renin‐angiotensin system inhibitors in several clinical trials.
Koichi Yamamoto +8 more
doaj +1 more source
DEVELOPMENT OF ASSAY METHOD AND FORCED DEGRADATION STUDY OF VALSARTAN AND SACUBITRIL BY RP-HPLC IN TABLET FORMULATION [PDF]
Objective: A stability-indicating high performance liquid chromatographic (HPLC) method was developed and validated for the estimation of combined tablet formulation of valsartan and sacubitril.Methods: Chromatographic separation was optimized by ...
Naazneen, S., Sridevi, A.
core +1 more source
Background and aim:Heart failure with preserved ejection fraction (HFpEF) is associated with an increased risk of heart failure (HF) hospitalizations and cardiovascular death (CVD).
Ronen Arbel +9 more
doaj +1 more source

